ENGOT-ov24-NSGO/AVANOVA
Study documentation (link to documents, only accessible with password to www.nsgo.org). Click HERE for access.
Sponsor | NSGO-CTU |
NSGO-CTU Project Manager | Nicole Buchner Vinum nicole.buchner.vinum@regionh.dk +45 3545 3311 |
Study Chair | Mansoor Raza Mirza +45 3545 9624 |
Drugs | Niraparib and Bevacizumab |
Phase | II |
Randomized trial | Yes |
Type | Open-label |
Total number of patients | 94 patients required |
Number of patients recruited | Recruitment statistics – link |
Trial status | Recruitment closed |
Date of first site activated | 02.03.2016 |
eCRF | Open Clinica Test – link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
Site List | Site List – link (protected information – access only with login) |
Protocol summary | ClinicalTrials.gov – link |